secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0000950170-23-071065
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix repays $1.06M of convertible bond via 2.5M shares and $600k cash; remaining principal $13.78M
--------------------------------------------------------------------------------

- Repayment of $1.06M principal and interest due Jan 7, 2024 using 2.5M ordinary shares and $600k cash.
- After settlement, remaining convertible bond principal reduced to $13.78M from $14.84M.
- 2.5M new ordinary shares admitted to AIM on December 21, 2023; total voting rights become 99,930,156.
- Shares issued under Section 3(a)(9) exemption; no registration required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023071065/0000950170-23-071065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023071065/rnlx-20231215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-071065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer